- Home
- MATH vs ELEV Comparison
MATH vs ELEV Comparison
Compare MATH & ELEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MATH
- ELEV
- Stock Information
- Founded
- MATH 2015
- ELEV 2019
- Country
- MATH Hong Kong
- ELEV United States
- Employees
- MATH N/A
- ELEV N/A
- Industry
- MATH Finance/Investors Services
- ELEV Biotechnology: Pharmaceutical Preparations
- Sector
- MATH Finance
- ELEV Health Care
- Exchange
- MATH Nasdaq
- ELEV Nasdaq
- Market Cap
- MATH 44.7M
- ELEV 37.6M
- IPO Year
- MATH N/A
- ELEV 2021
- Fundamental
- Price
- MATH $1.03
- ELEV $0.65
- Analyst Decision
- MATH
- ELEV Strong Buy
- Analyst Count
- MATH 0
- ELEV 5
- Target Price
- MATH N/A
- ELEV $7.20
- AVG Volume (30 Days)
- MATH 64.4K
- ELEV 716.1K
- Earning Date
- MATH 02-12-2025
- ELEV 11-06-2024
- Dividend Yield
- MATH N/A
- ELEV N/A
- EPS Growth
- MATH N/A
- ELEV N/A
- EPS
- MATH N/A
- ELEV N/A
- Revenue
- MATH $16,763,545.00
- ELEV N/A
- Revenue This Year
- MATH N/A
- ELEV N/A
- Revenue Next Year
- MATH N/A
- ELEV N/A
- P/E Ratio
- MATH N/A
- ELEV N/A
- Revenue Growth
- MATH 194.51
- ELEV N/A
- 52 Week Low
- MATH $0.80
- ELEV $0.44
- 52 Week High
- MATH $2.27
- ELEV $5.83
- Technical
- Relative Strength Index (RSI)
- MATH 47.64
- ELEV 57.75
- Support Level
- MATH $0.99
- ELEV $0.61
- Resistance Level
- MATH $1.06
- ELEV $0.70
- Average True Range (ATR)
- MATH 0.07
- ELEV 0.07
- MACD
- MATH 0.02
- ELEV 0.00
- Stochastic Oscillator
- MATH 60.98
- ELEV 50.69
About MATH Metalpha Technology Holding Limited
Metalpha Technology Holding Ltd is to enable the transition towards digital asset technology. The company aims to provide a crypto derivatives product services for users world-wide. The company has three operating segments. The Longyun operating segment reflects the Company's crowdfunding and incubation business. The Dacheng Liantong operating segment reflects the Company's business of platform services. The Metalpha operating segment reflects the Company's business of proprietary trading of digital assets. The Company is generates its revenue from Hong Kong.
About ELEV Elevation Oncology Inc. Common stock
Elevation Oncology Inc is an oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations. Its lead program is focused on neuregulin-1, or NRG1, fusions, which are rare genomic alterations that have the potential to be therapeutically actionable through targeted HER3 inhibition.